Skip to main content

Table 4 Severity of CAD/ STEMI, treatment modalities and outcome according to SES-group

From: Socially disadvantaged city districts show a higher incidence of acute ST-elevation myocardial infarctions with elevated cardiovascular risk factors and worse prognosis

  G1 (n = 519) G2 (n = 813) G3 (n = 1554) G4 (n = 576) p-value
Severity of myocardial infarction
 Number of coronary vesssels affected ±SD 1.99 ± 0.8 1.94 ± 0.8 1.91 ± 0.8 1.84 ± 0.8 0.09
 Cardiogenic shock (%) 12.1 13.1 12.0 12.4 0.8
 Prehospital CPR (%) 10.9 11.3 10.8 10.3 0.5
 Subacute MI(%) a 19.3 23.9 20.5 19.9 0.8
 Mean peak CK (U/l) ± SD 1599 ± 1679 1838 ± 2019 1913 ± 2188 2025 ± 2167 <0.01
 Peak CK > 3000 U/l (%) 13.7 20.5 20.9 23.3 <0.01
 Post AMI LVEF in % ± SD 49.6 ± 9 48.9 ± 10 48.4 ± 11 47.5 ± 10 <0.01
 LVEF <40% (%) 10.4 13.8 15.8 16.3 0.01
Treatment modalitites
 Primary PCI (%) 89.0 91.1 89.9 90.9 0.9
 CABG (%) 6.1 3.9 4.8 3.4 0.14
 Conservative therapy regimen (%) 4.8 4.9 5.2 5.7 0.8
 Door to balloon time in min (median ± SD) 48 ± 32 43 ± 44.5 46 ± 40 44 ± 41 0.74
 GP2b3a-Inhibitors (%) 70 67 66 70 0.7
 ASA (at discharge) (%) 94 96 94 95 0.64
 ADP-Antagon. (ad) (%) 90 90.5 90 94 0.23
 Beta-blockers (ad) (%) 83 84 80 84 0.25
 Statins (ad) (%) 86 87 87 86 0.9
 ACE/ATR-Inhibitors (ad) (%) 77 80 79 79 0.9
Outcome
 Mortality <72 h (%) 3.9 3.6 3.9 4.2 0.71
 Inhospital mortality (%) 8.8 7.6 7.9 8.1 0.71
 1-year-mortality (%) 15.7 15.1 14.9 16.3 0.9
 1-year-MACCE (%) 19.2 19.5 19.1 20.4 0.8
 5-year-mortality (%) 23.9 27.7 25.7 28.3 0.46
 5-year-MACCE (%) 30.8 35.7 36.0 41.1 0.02
  1. asubacute MI was defined as onset of symptoms >12 h before admission to PCI- center and/or signs of subacute STEMI in initial ECG